Business Name: |
John M Benbow Md |
Contact Person: |
John Benbow |
Address: |
110 Bridlewood Place Ne, Concord, North Carolina 28025 |
Phone Number: |
(704) 788-1844 |
Annual Revenue (USD): |
$100.000 to $499.999 |
Founding Year: |
2007 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Physicians Offices |
SIC Code: |
8011 |
NAICS Code: |
621111 |
Share This Business: |
|
Related Businesses: |
Jennifer Statis Md - Concord, NC 28025 Mark Braun Md - Concord, NC 28025 Carlos Jorge MD - Concord, NC 28025 Christopher Snyder Iii Md Office - Concord, NC 28025 Morgan Amy Md Office - Concord, NC 28025 Barone Barbara MD - Concord, NC 28025 Michele Schaefer Md - Concord, NC 28025 Robert W Surratt Md Res - Concord, NC 28025 Spain Blake A MD - Concord, NC 28025 Donald L Mcalexander Md - Concord, NC 28025 North East Rheumatology - Concord, NC 28025 Daniel Bernstein Md - Concord, NC 28025 Thea Pfeifer Md - Concord, NC 28025 Christopher Connelly Md - Concord, NC 28025 George L Gaunt Md - Concord, NC 28025 Center For Arthritis & Rheumatic - Concord, NC 28025 Kelvin D Kable Md - Concord, NC 28025 Michael C Jones Md Res - Concord, NC 28025 Sikes Thomas E Jr Md Res - Concord, NC 28025 Robert H Beaver Md - Concord, NC 28025 |
The company John M Benbow Md provides B2C services in the form of Physicians Offices from its single location in North Carolina.
1 to 4 employees work for John M Benbow Md, and the business now earns $100.000 to $499.999 per annum.
John M Benbow Md was launched in 2007 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact John M Benbow Md, please call John Benbow with the phone number (704) 788-1844 or visit its single location at 110 Bridlewood Place Ne in Concord, North Carolina 28025.
The location of the single location can also be found using the coordinates 35.455428,-80.577419.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.